ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
During the Trading Day
| 19.44 |  +0.16 / +0.83% |
Data as of 3:59pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 19.44 |  0.00 / 0.00% |
Volume: 5.7K |
Latest ACAD News | Press Releases
| The Recent Performance of 'Baker Brother Biotech Stocks' is Awful Apr 15 / TheStreet.com | Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP) Apr 14 / Investing Channel |
Today’s Trading
| Previous close | 19.28 |
| Today’s open | 19.11 |
| Day’s range | 18.39 - 19.97 |
| Volume | 2,154,196 |
| Average volume (3 months) | 2,224,977 |
| Market cap | $2.0B |
| Dividend yield | -- |
Data as of 3:59pm ET, 04/17/2014
Growth & Valuation
| Earnings growth (last year) | -15.79% |
| Earnings growth (this year) | -25.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -76.67% |
| P/E ratio | NM |
| Price/Sales | 1,870.76 |
| Price/Book | 10.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AKRXAkorn Inc | +0.10 | +0.44% |
| CLVSClovis Oncology Inc | -1.37 | -2.44% |
| RAREUltragenyx Pharmaceu... | -2.67 | -5.90% |
| IPXLImpax Laboratories I... | -0.39 | -1.60% |
Data as of 3:59pm ET, 04/17/2014
Financials
| Next reporting date | May 6, 2014 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$37.9M |
| Net profit margin | -3,314.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Uli Hacksell |
Treasurer, Chief Financial & Business Officer Thomas H. Aasen |
Corporate headquarters San Diego, California |
Forecasts
